Patent · US Expired

Benzodiazepine antagonistic .beta.-carboline derivatives and compositions thereof

US4600715A · kind A · utility

5Cited by
2References
44Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 1984
Grant dateJul 15, 1986
Priority date
Expiry dateJun 22, 2004

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

.beta.-carboline derivatives of general Formula I ##STR1## wherein R.sup.3 is ##STR2## wherein R.sup.5 is C.sub.1-5 alkyl, R.sup.6 is lower alkyl, aralkyl, or alkoxyalkyl of up to 7 carbon atoms, and R.sup.7 and R.sup.8 are hydrogen C.sub.1-5 alkyl, or, collectively with the amido nitrogen atom, piperidino, PA0 R.sup.4 is hydrogen, C.sub.1-3 alkyl, or CH.sub.2 OR.sup.9 wherein R.sup.9 is C.sub.1-3 alkyl, atoms, and PA0 R.sup.A is --COOR.sup.10 ##STR3## wherein R.sup.10 is hydrogen, lower alkyl, alkoxyalkyl or alkenyl of up to 5 carbon atoms, or benzyl, or X is oxygen or sulfur, and R.sup.11 and R.sup.12 each are hydrogen, lower alkyl or alkenyl or, collectively with the amido nitrogen atom, represent a hetero ring, are prepared by conventional methods and exhibit, inter alia, an effect on the central nervous system and are suitable for use as psychopharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.